#Sustainability #Innovation #Haier Biomedical

Haier Biomedical's Commitment to a Sustainable Future

Haier Biomedical, a leader in life sciences and medical solutions, has recently released its 2025 Sustainability Report. This document provides an extensive overview of its measurable progress in environmental, social, and governance aspects, emphasizing the company’s commitment to creating safer, sustainable, inclusive, and accessible healthcare throughout the world.

Within its LIFE sustainability framework—Leadership, Integrity, Future, and Ecosystem—Haier Biomedical actively supports and implements the 17 Sustainable Development Goals (SDGs) set forth by the United Nations. Through continual technological innovation and locally integrated strategies, the company drives public health initiatives globally, focusing on strengthening local service networks, advancing cutting-edge scientific research, and fostering sustainable development across industrial chains with low-carbon solutions.

Tan Lixia, the President of Haier Biomedical, stated, “In 2025, we achieved three strategic advancements—from products to scenarios, from China to the globe, and from a single industry to a platform ecosystem. Guided by our philosophy of 'Smart Life Science', we continue deepening our focus on green and low-carbon innovation while enhancing global accessibility to health under our core framework of 'LIFE'.”

Prioritizing Research and Development

Haier Biomedical prioritizes Research and Development (R&D) as its strategic focus. The company has established a robust three-tier management structure that balances resource allocation, accelerates technological advancements, and speeds up product development. From milestone review committees to monthly progress reports and weekly operational meetings, this strategic alignment has produced exceptional results:

• - R&D personnel account for 28.56% of the workforce, with total R&D investment reaching 323 million yuan (approximately $47.25 million).
• - New invention patents have increased by 50% year-over-year, with non-storage-related patents now representing 73% of the portfolio.
• - The company holds 428 software copyrights and has received 51 provincial or higher-level awards for science and technology, as well as participating in the establishment of 75 national, industrial, group, and technical standards.
• - They possess 34 technologies recognized as internationally leading while achieving a record of 0.70 patents and 0.18 software copyrights per million yuan in revenue.

Integrating AI into Product Development

Haier Biomedical is also integrating artificial intelligence into its product R&D, launching